Review Article - (2013) Volume 4, Issue 6

Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy

Raghavendra Gowda1,5,6,7, Nathan R. Jones1, Shubhadeep Banerjee1,5,6 and Gavin P. Robertson1,2,3,4,5,6,7*
1Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
2Department of Pathology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
3Department of Dermatology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
4Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
5Penn State Hershey Melanoma Center, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
6Penn State Melanoma Therapeutics Program, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
7The Foreman Foundation for Melanoma Research, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
*Corresponding Author: